Beyond Body Size: Adiponectin as a Key Player in Obesity-Driven Cancers

References

• Katsiki N, Mikhailidis DP, Banach M. Leptin, cardiovascular diseases and type 2 diabetes mellitus. Acta Pharmacol Sin. 2018; 39(7):1176–88. doi:10.1038/aps.2018.40.
   PubMed Web of Science ®Google Scholar
• Atawia RT, Bunch KL, Toque HA, Caldwell RB, Caldwell RW. Mechanisms of obesity-induced metabolic and vascular dysfunctions. Front Biosci (Landmark Ed). 2019; 24(5):890–934. doi:10.2741/4758.
   PubMedGoogle Scholar
• Parida S, Siddharth S, Sharma D. Adiponectin, Obesity, and Cancer: clash of the Bigwigs in Health and Disease. Int J Mol Sci. 2019; 2220(10):2519. doi:10.3390/ijms20102519.
   PubMed Web of Science ®Google Scholar
• Kim DS, Scherer PE. Obesity, diabetes, and increased cancer progression. Diabetes Metab J. 2021; 45(6):799–812. doi:10.4093/dmj.2021.0077.
   PubMed Web of Science ®Google Scholar
• Tumminia A, Vinciguerra F, Parisi M, Graziano M, Sciacca L, Baratta R, Frittitta L. Adipose Tissue, Obesity and Adiponectin: role in Endocrine CancerRisk. Int J Mol Sci. 2019; 20(12):2863. doi:10.3390/ijms20122863.
   PubMed Web of Science ®Google Scholar
• Calle EE, Thun MJ. Obesity and cancer. Oncogene. 2004; 23(38):6365–78. doi:10.1038/sj.onc.1207751.
   PubMed Web of Science ®Google Scholar
• Vigneri R, Goldfine ID, Frittitta L. Insulin, insulin receptors, and cancer. J Endocrinol Invest. 2016; 39(12):1365–76. doi:10.1007/s40618-016-0508-7.
   PubMed Web of Science ®Google Scholar
• Neumann E, Hasseli R, Ohl S, Lange U, Frommer KW, Müller-Ladner U. Adipokines and Autoimmunity in Inflammatory Arthritis. Cells. 2021; 10(2):216. doi:10.3390/cells10020216.
   PubMed Web of Science ®Google Scholar
• Reilly SM, Saltiel AR. Adapting to obesity with adipose tissue inflammation. Nat Rev Endocrinol. 2017; 13(11):633–43. doi:10.1038/nrendo.2017.90.
   PubMed Web of Science ®Google Scholar
• Giralt M, Cereijo R, Villarroya F. Adipokines and the Endocrine Role of Adipose Tissues. Handb Exp Pharmacol. 2016;233:265–82. doi:10.1007/164_2015_6.
   PubMedGoogle Scholar
• Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257(1):79–83. doi:10.1006/bbrc.1999.0255.
   PubMed Web of Science ®Google Scholar
• Vansaun MN. Molecular pathways: adiponectin and leptin signaling in cancer. Clin Cancer Res. 2013; 19(8):1926–32. doi:10.1158/1078-0432.CCR-12-0930.
   PubMed Web of Science ®Google Scholar
• Booth A, Magnuson A, Fouts J, Foster M. Adipose tissue, obesity and adipokines: role in cancer promotion. Horm Mol Biol Clin Investig. 2015; 21(1):57–74. doi:10.1515/hmbci-2014-0037.
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003;423(6941):762–9. doi:10.1038/nature01705.
   PubMed Web of Science ®Google Scholar
• Scherer PE. The Multifaceted Roles of Adipose Tissue-Therapeutic Targets for Diabetes and Beyond: the 2015 Banting Lecture. Diabetes. 2016; 65(6):1452–61. doi:10.2337/db16-0339.
   PubMed Web of Science ®Google Scholar
• Katira A, Tan PH. Evolving role of adiponectin in cancer-controversies and update. Cancer Biol Med. 2016; 13(1):101–19. doi:10.28092/j.issn.2095-3941.2015.0092.
   PubMed Web of Science ®Google Scholar
• Boroń D, Nowakowski R, Grabarek BO, Zmarzły N, Opławski M. Expression Pattern of Leptin and Its Receptors in Endometrioid Endometrial Cancer. J Clin Med. 2021; 10(13):2787. doi:10.3390/jcm10132787.
   PubMed Web of Science ®Google Scholar
• Ghalandari H, Hosseini-Esfahani F, Mirmiran P. The Association of Polymorphisms in Leptin/Leptin Receptor Genes and Ghrelin/Ghrelin Receptor Genes With Overweight/Obesity and the Related Metabolic Disturbances: a Review. Int J Endocrinol Metab. 2015; 13(3):e19073. doi:10.5812/ijem.19073v2.
   PubMedGoogle Scholar
• Palin MF, Bordignon VV, Murphy BD. Adiponectin and the control of female reproductive functions. Vitam Horm. 2012;90:239–87. doi:10.1016/B978-0-12-398313-8.00010-5.
   PubMed Web of Science ®Google Scholar
• Wan J, Yin Y, Zhao M, Shen F, Chen M, Chen Q. The positivity of G-protein-coupled receptor-30 (GPR 30), an alternative estrogen receptor is not different between type 1 and type 2 endometrial cancer. Oncotarget. 2017; 8(53):90897–904. doi:10.18632/oncotarget.18545.
   PubMedGoogle Scholar
• Wang Y, Lam KS, Xu JY, Lu G, Xu LY, Cooper GJ, Xu A. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem. 2005; 280(18):18341–7. doi:10.1074/jbc.M501149200.
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006; 6(10):772–83. doi:10.1038/nri1937.
   PubMed Web of Science ®Google Scholar
• Nguyen K, Tran MN, Rivera A, Cheng T, Windsor GO, Chabot AB, Cavanaugh JE, Collins-Burow BM, Lee SB, Drewry DH, et al. MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer Types. Front Biosci (Landmark Ed). 2022;27(5):167. 23doi:10.31083/j.fbl2705167.
   PubMed Web of Science ®Google Scholar
• Luo Z, Saha AK, Xiang X, Ruderman NB. AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci. 2005; Feb26(2):69–76. doi:10.1016/j.tips.2004.12.011.
   PubMed Web of Science ®Google Scholar
• Gormand A, Henriksson E, Ström K, Jensen TE, Sakamoto K, Göransson O. Regulation of AMP-activated protein kinase by LKB1 and CaMKK in adipocytes. J Cell Biochem. 2011; 112(5):1364–75. doi:10.1002/jcb.23053.
   PubMed Web of Science ®Google Scholar
• Li NS, Zou JR, Lin H, Ke R, He XL, Xiao L, Huang D, Luo L, Lv N, Luo Z. LKB1/AMPK inhibits TGF-β1 production and the TGF-β signaling pathway in breast cancer cells. Tumour Biol. 2016; 37(6):8249–58. doi:10.1007/s13277-015-4639-9.
   PubMedGoogle Scholar
• Liu H, Wu X, Luo J, Zhao L, Li X, Guo H, Bai H, Cui W, Guo W, Feng D, et al. Adiponectin peptide alleviates oxidative stress and NLRP3 inflammasome activation after cerebral ischemia-reperfusion injury by regulating AMPK/GSK-3β. Exp Neurol. 2020;329:113302. doi:10.1016/j.expneurol.2020.113302.
   PubMed Web of Science ®Google Scholar
• Wang A, Li T, An P, Yan W, Zheng H, Wang B, Mu Y. Exendin-4 Upregulates Adiponectin Level in Adipocytes via Sirt1/Foxo-1 Signaling Pathway. PLoS One. 2017; 12(1):e0169469. doi:10.1371/journal.pone.0169469.
   PubMed Web of Science ®Google Scholar
• Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev. 2012; 33(4):547–94. doi:10.1210/er.2011-1015.
   PubMed Web of Science ®Google Scholar
• Di Zazzo E, Polito R, Bartollino S, Nigro E, Porcile C, Bianco A, Daniele A, Moncharmont B. Adiponectin as Link Factor between Adipose Tissue and Cancer. Int J Mol Sci. 2019; 20(4):839. doi:10.3390/ijms20040839.
   PubMed Web of Science ®Google Scholar
• Pérez-Hernández AI, Catalán V, Gómez-Ambrosi J, Rodríguez A, Frühbeck G. Mechanisms linking excess adiposity and carcinogenesis promotion. Front Endocrinol (Lausanne). 2014; 5:65. doi:10.3389/fendo.2014.00065.
   PubMed Web of Science ®Google Scholar
• Lee CH, Woo YC, Wang Y, Yeung CY, Xu A, Lam KS. Obesity, adipokines and cancer: an update. Clin Endocrinol (Oxf). 2015; 83(2):147–56. doi:10.1111/cen.12667.
   PubMed Web of Science ®Google Scholar
• Jardé T, Perrier S, Vasson MP, Caldefie-Chézet F. Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer. 2011; 47(1):33–43. doi:10.1016/j.ejca.2010.09.005.
   PubMed Web of Science ®Google Scholar
• Vona-Davis L, Rose DP. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer. 2007; 14(2):189–206. doi:10.1677/ERC-06-0068.
   PubMed Web of Science ®Google Scholar
• Jeong YJ, Bong JG, Park SH, Choi JH, Oh HK. Expression of leptin, leptin receptor, adiponectin, and adiponectin receptor in ductal carcinoma in situ and invasive breast cancer. J Breast Cancer. 2011; 14(2):96–103. doi:10.4048/jbc.2011.14.2.96.
   PubMed Web of Science ®Google Scholar
• Akrida I, Papadaki H. Adipokines and epithelial-mesenchymal transition (EMT) in cancer. Mol Cell Biochem. 2023;478 (11):2419–33. doi:10.1007/s11010-023-04670-x.
   PubMed Web of Science ®Google Scholar
• Anderson NM, Simon MC. The tumor microenvironment. Curr Biol. 2020; Aug 1730(16):R921–R925. doi:10.1016/j.cub.2020.06.081.
   PubMed Web of Science ®Google Scholar
• Li L, Wu LL. Adiponectin and interleukin-6 in inflammation-associated disease. Vitam Horm. 2012;90:375–95. doi:10.1016/B978-0-12-398313-8.00014-2.
   PubMed Web of Science ®Google Scholar
• Zhao C, Wu M, Zeng N, Xiong M, Hu W, Lv W, Yi Y, Zhang Q, Wu Y. Cancer-associated adipocytes: emerging supporters in breast cancer. J Exp Clin Cancer Res. 2020; Aug 1239(1):156. doi:10.1186/s13046-020-01666-z.
   PubMed Web of Science ®Google Scholar
• Wieder R. Fibroblasts as Turned Agents in Cancer Progression. Cancers (Basel). 2023; 15(7):2014. doi:10.3390/cancers15072014.
   PubMed Web of Science ®Google Scholar
• Taddei ML, Giannoni E, Comito G, Chiarugi P. Microenvironment and tumor cell plasticity: an easy way out. Cancer Lett. 2013; 341(1):80–96. doi:10.1016/j.canlet.2013.01.042.
   PubMed Web of Science ®Google Scholar
• Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun. 2004; 323(2):630–5. doi:10.1016/j.bbrc.2004.08.145.
   PubMed Web of Science ®Google Scholar
• Senolt L, Pavelka K, Housa D, Haluzík M. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine. 2006; Sep35(5-6):247–52. doi:10.1016/j.cyto.2006.09.002.
   PubMed Web of Science ®Google Scholar
• Neumeier M, Weigert J, Schäffler A, Wehrwein G, Müller-Ladner U, Schölmerich J, Wrede C, Buechler C. Different effects of adiponectin isoforms in human monocytic cells. J Leukoc Biol. 2006; 79(4):803–8. doi:10.1189/jlb.0905521.
   PubMed Web of Science ®Google Scholar
• Weigert J, Neumeier M, Schäffler A, Fleck M, Schölmerich J, Schütz C, Buechler C. The adiponectin paralog CORS-26 has anti-inflammatory properties and is produced by human monocytic cells. FEBS Lett. 2005; Oct 24579(25):5565–70. doi:10.1016/j.febslet.2005.09.022.
   PubMed Web of Science ®Google Scholar
• Ebina K, Fukuhara A, Ando W, Hirao M, Koga T, Oshima K, Matsuda M, Maeda K, Nakamura T, Ochi T, et al. Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction. Clin Rheumatol. 2009;28(4):445–51. doi:10.1007/s10067-008-1074-y.
   PubMed Web of Science ®Google Scholar
• Ehling A, Schäffler A, Herfarth H, Tarner IH, Anders S, Distler O, Paul G, Distler J, Gay S, Schölmerich J, et al. The potential of adiponectin in driving arthritis. J Immunol. 2006;176(7):4468–78. doi:10.4049/jimmunol.176.7.4468.
   PubMed Web of Science ®Google Scholar
• Lakkis NA, Musharafieh UM, Issa HG, Osman MH. Lung Cancer and Risk Factors in Lebanon: epidemiology, Temporal Trends, and Comparison to Countries From Different Regions in the World. Cancer Control. 2023; 30:10732748231169596. doi:10.1177/10732748231169596.
   Web of Science ®Google Scholar
• Kariagina A, Doseff AI. Anti-Inflammatory Mechanisms of Dietary Flavones: tapping into Nature to Control Chronic Inflammation in Obesity and Cancer. Int J Mol Sci. 2022; 23(24):15753. doi:10.3390/ijms232415753.
   PubMed Web of Science ®Google Scholar
• Jiang L, Sun YQ, Brumpton BM, Langhammer A, Chen Y, Mai XM. Body mass index and incidence of lung cancer in the HUNT study: using observational and Mendelian randomization approaches. BMC Cancer. 2022; 22(1):1152. doi:10.1186/s12885-022-10215-0.
   PubMed Web of Science ®Google Scholar
• Hidayat K, Du X, Chen G, Shi M, Shi B. Abdominal Obesity and Lung Cancer Risk: systematic Review and Meta-Analysis of Prospective Studies. Nutrients. 2016; 8(12):810. doi:10.3390/nu8120810.
   PubMed Web of Science ®Google Scholar
• Daniele A, De Rosa A, Nigro E, Scudiero O, Capasso M, Masullo M, de Laurentiis G, Oriani G, Sofia M, Bianco A. Adiponectin oligomerization state and adiponectin receptors airway expression in chronic obstructive pulmonary disease. Int J Biochem Cell Biol. 2012; 44(3):563–9. doi:10.1016/j.biocel.2011.12.016.
   PubMed Web of Science ®Google Scholar
• Nigro E, Perrotta F, Monaco ML, Polito R, Pafundi PC, Matera MG, Daniele A, Bianco A. Implications of the Adiponectin System in Non-Small Cell Lung Cancer Patients: a Case-Control Study. Biomolecules. 2020; 10(6):926. doi:10.3390/biom10060926.
   PubMed Web of Science ®Google Scholar
• Petridou ET, Mitsiades N, Gialamas S, Angelopoulos M, Skalkidou A, Dessypris N, Hsi A, Lazaris N, Polyzos A, Syrigos C, et al. Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies. Oncology. 2007;73(3-4):261–9. doi:10.1159/000127424.
   PubMed Web of Science ®Google Scholar
• Gulen ST, Karadag F, Karul AB, Kilicarslan N, Ceylan E, Kuman NK, Cildag O. Adipokines and systemic inflammation in weight-losing lung cancer patients. Lung. 2012; 190(3):327–32. doi:10.1007/s00408-011-9364-6.
   PubMed Web of Science ®Google Scholar
• Boura P, Grapsa D, Loukides S, Angelidou M, Tsakanika K, Syrigos N, Gkiozos I. The prognostic value of serum and bronchoalveolar lavage levels of adiponectin in advanced non-small-cell lung cancer. Lung Cancer Manag. 2017; 6(2):55–65. doi:10.2217/lmt-2016-0018.
   PubMedGoogle Scholar
• Karapanagiotou EM, Tsochatzis EA, Dilana KD, Tourkantonis I, Gratsias I, Syrigos KN. The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC). Lung Cancer. 2008; 61(3):391–7. doi:10.1016/j.lungcan.2008.01.018.
   PubMed Web of Science ®Google Scholar
• Wang RP, Wang XH, Li ZM, Sun JR. Changes in serum inflammatory factors, adiponectin, intestinal flora and immunity in patients with non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2020; 24(20):10566–72. doi:10.26355/eurrev_202010_23412.
   PubMed Web of Science ®Google Scholar
• Denzel MS, Scimia MC, Zumstein PM, Walsh K, Ruiz-Lozano P, Ranscht B. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest. 2010; 120(12):4342–52. doi:10.1172/JCI43464.
   PubMed Web of Science ®Google Scholar
• Tang D, Liu H, Zhao Y, Qian D, Luo S, Patz EF, Jr, Su L, Shen S, ChristianI DC, Gao W, et al. Genetic variants of BIRC3 and NRG1 in the NLRP3 inflammasome pathway are associated with non-small cell lung cancer survival. Am J Cancer Res. 2020;10(8):2582–95.
   PubMed Web of Science ®Google Scholar
• Nigro E, Scudiero O, Sarnataro D, Mazzarella G, Sofia M, Bianco A, Daniele A. Adiponectin affects lung epithelial A549 cell viability counteracting TNFα and IL-1ß toxicity through AdipoR1. Int J Biochem Cell Biol. 2013; 45(6):1145–53. doi:10.1016/j.biocel.2013.03.003.
   PubMed Web of Science ®Google Scholar
• Illiano M, Nigro E, Sapio L, Caiafa I, Spina A, Scudiero O, Bianco A, Esposito S, Mazzeo F, Pedone PV, et al. Adiponectin down-regulates CREB and inhibits proliferation of A549 lung cancer cells. Pulm Pharmacol Ther. 2017;45:114–20. doi:10.1016/j.pupt.2017.05.009.
   PubMed Web of Science ®Google Scholar
• Chen HM, Yang CM, Chang JF, Wu CS, Sia KC, Lin WN. AdipoR-increased intracellular ROS promotes cPLA2 and COX-2 expressions via activation of PKC and p300 in adiponectin-stimulated human alveolar type II cells. Am J Physiol Lung Cell Mol Physiol. 2016; 311(2):L255–69. doi:10.1152/ajplung.00218.2015.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394–424. doi:10.3322/caac.21492.
   PubMed Web of Science ®Google Scholar
• Yu Z, Tang S, Ma H, Duan H, Zeng Y. Association of serum adiponectin with breast cancer: a meta-analysis of 27 case-control studies. Medicine (Baltimore). 2019; 98(6):e14359. doi:10.1097/MD.0000000000014359.
   PubMed Web of Science ®Google Scholar
• Güven HE, Doğan L, Gülçelik MA, Gülçelik NE. Adiponectin: a Predictor for Breast Cancer Survival? Eur J Breast Health. 2019; 15(1):13–7. doi:10.5152/ejbh.2018.4349. PMI
   PubMed Web of Science ®Google Scholar
• Decensi A, Robertson C, Guerrieri-Gonzaga A, Serrano D, Cazzaniga M, Mora S, Gulisano M, Johansson H, Galimberti V, Cassano E, et al. Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women. J Clin Oncol. 2009;27(23):3749–56. Aug 10doi:10.1200/JCO.2008.19.3797.
   PubMed Web of Science ®Google Scholar
• Dos Santos E, Benaitreau D, Dieudonne MN, Leneveu MC, Serazin V, Giudicelli Y, Pecquery R. Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells. Oncol Rep. 2008; 20(4):971–7.
   PubMed Web of Science ®Google Scholar
• Grossmann ME, Ray A, Nkhata KJ, Malakhov DA, Rogozina OP, Dogan S, Cleary MP. Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev. 2010; 29(4):641–53. doi:10.1007/s10555-010-9252-1.
   PubMed Web of Science ®Google Scholar
• Tian YF, Chu CH, Wu MH, Chang CL, Yang T, Chou YC, Hsu GC, Yu CP, Yu JC, Sun CA. Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr Relat Cancer. 2007; 14(3):669–77. doi:10.1677/ERC-06-0089.
   PubMed Web of Science ®Google Scholar
• Cust AE, Stocks T, Lukanova A, Lundin E, Hallmans G, Kaaks R, Jonsson H, Stattin P. The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study. Breast Cancer Res Treat. 2009; 113(3):567–76. doi:10.1007/s10549-008-9958-8.
   PubMed Web of Science ®Google Scholar
• Hancke K, Grubeck D, Hauser N, Kreienberg R, Weiss JM. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients. Breast Cancer Res Treat. 2010; 119(2):367– doi:10.1007/s10549-009-0577-9.
   PubMed Web of Science ®Google Scholar
• Macis D, Gandini S, Guerrieri-Gonzaga A, Johansson H, Magni P, Ruscica M, Lazzeroni M, Serrano D, Cazzaniga M, Mora S, et al. Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer. J Clin Oncol. 2012; 30(2):151–7. doi:10.1200/JCO.2011.35.2237.
   PubMed Web of Science ®Google Scholar
• Gu L, Cao C, Fu J, Li Q, Li DH, Chen MY. Serum adiponectin in breast cancer: a meta-analysis. Medicine (Baltimore). 2018; 97(29):e11433. doi:10.1097/MD.0000000000011433.
   PubMed Web of Science ®Google Scholar
• Lyons A, Coleman M, Riis S, Favre C, O’Flanagan CH, Zhdanov AV, Papkovsky DB, Hursting SD, O’Connor R. Insulin-like growth factor 1 signaling is essential for mitochondrial biogenesis and mitophagy in cancer cells. J Biol Chem. 2017; 292(41):16983–98. doi:10.1074/jbc.M117.792838.
   PubMed Web of Science ®Google Scholar
• Guan X, Yan Q, Wang D, Du G, Zhou J. IGF-1 Signaling Regulates Mitochondrial Remodeling during Myogenic Differentiation. Nutrients. 2022; 14(6):1249. doi:10.3390/nu14061249.
   PubMed Web of Science ®Google Scholar
• Bråkenhielm E, Veitonmäki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, Funahashi T, Cao Y. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A. 2004; 101(8):2476–81. doi:10.1073/pnas.0308671100.
   PubMed Web of Science ®Google Scholar
• Gavrila A, Chan JL, Yiannakouris N, Kontogianni M, Miller LC, Orlova C, Mantzoros CS. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab. 2003; 88(10):4823–31. doi:10.1210/jc.2003-030214.
   PubMed Web of Science ®Google Scholar
• Georgiou GP, Provatopoulou X, Kalogera E, Siasos G, Menenakos E, Zografos GC, Gounaris A. Serum resistinis inversely related to breast cancer risk in premenopausal women. Breast. 2016; 29:163–9. doi:10.1016/j.breast.2016.07.025.
   PubMed Web of Science ®Google Scholar
• Guo MM, Duan XN, Cui SD, Tian FG, Cao XC, Geng CZ, Fan ZM, Wang X, Wang S, Jiang HC, et al. Circulating High-Molecular-Weight (HMW) Adiponectin Level Is Related with Breast Cancer Risk Better than Total Adiponectin: a Case-Control Study. PLoS One. 2015;10(6):e0129246. doi:10.1371/journal.pone.0129246.
   PubMed Web of Science ®Google Scholar
• Wang Y, Lam JB, Lam KS, Liu J, Lam MC, Hoo RL, Wu D, Cooper GJ, Xu A. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res. 2006; 166(23):11462–70. doi:10.1158/0008-5472.CAN-06-1969.
   PubMed Web of Science ®Google Scholar
• Jiang J, Fan Y, Zhang W, Shen Y, Liu T, Yao M, Gu J, Tu H, Gan Y. Adiponectin Suppresses Human Pancreatic Cancer Growth through Attenuating the β-Catenin Signaling Pathway. Int J Biol Sci. 2019; 15(2):253–64. doi:10.7150/ijbs.27420.
   PubMed Web of Science ®Google Scholar
• Nakayama S, Miyoshi Y, Ishihara H, Noguchi S. Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis. Breast Cancer Res Treat. 2008; 112(3):405–10. doi:10.1007/s10549-007-9874-3.
   PubMed Web of Science ®Google Scholar
• Chung SJ, Nagaraju GP, Nagalingam A, Muniraj N, Kuppusamy P, Walker A, Woo J, Győrffy B, Gabrielson E, Saxena NK, et al. ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis. Autophagy. 2017;13(8):1386–403. doi:10.1080/15548627.2017.1332565.
   PubMed Web of Science ®Google Scholar
• Pham DV, Park PH. Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming. J Exp Clin Cancer Res. 2022; 41(1):9. doi:10.1186/s13046-021-02223-y.
   PubMed Web of Science ®Google Scholar
• Mauro L, Pellegrino M, De Amicis F, Ricchio E, Giordano F, Rizza P, Catalano S, Bonofiglio D, Sisci D, Panno ML, et al. Evidences that estrogen receptor α interferes with adiponectin effects on breast cancer cell growth. Cell Cycle. 2014;13(4):553–64. doi:10.4161/cc.27455.
   PubMed Web of Science ®Google Scholar
• Mauro L, Naimo GD, Gelsomino L, Malivindi R, Bruno L, Pellegrino M, Tarallo R, Memoli D, Weisz A, Panno ML, et al. Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer. Faseb J. 2018;32(8):4343–55. doi:10.1096/fj.201701315R.
   PubMed Web of Science ®Google Scholar
• Kang JH, Lee YY, Yu BY, Yang BS, Cho KH, Yoon DK, Roh YK. Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch Pharm Res. 2005; 28(11):1263–9. doi:10.1007/BF02978210.
   PubMed Web of Science ®Google Scholar
• Naimo GD, Paolì A, Giordano F, Forestiero M, Panno ML, Andò S, Mauro L. Unraveling the Role of Adiponectin Receptors in Obesity-Related Breast Cancer. Int J Mol Sci. 2023; 24(10):8907. doi:10.3390/ijms24108907. PMID: 37240258; PMCID: PMC10218957.)
   PubMed Web of Science ®Google Scholar
• Fakhri N, Chad MA, Lahkim M, Houari A, Dehbi H, Belmouden A, El Kadmiri N. Risk factors for breast cancer in women: an update review. Med Oncol. 2022; Sep 739(12):197. doi:10.1007/s12032-022-01804-x.
   PubMed Web of Science ®Google Scholar
• Poorolajal J, Heidarimoghis F, Karami M, Cheraghi Z, Gohari-Ensaf F, Shahbazi F, Zareie B, Ameri P, Sahraee F. Factors for the Primary Prevention of Breast Cancer: A Meta-Analysis of Prospective Cohort Studies. J Res Health Sci. 2021; Jul 2021(3):e00520–e00520. doi:10.34172/jrhs.2021.57.
   PubMed Web of Science ®Google Scholar
• Pang Y, Wei Y, Kartsonaki C. Associations of adiposity and weight change with recurrence and survival in breast cancer patients: a systematic review and meta-analysis. Breast Cancer. 2022; 29(4):575–88. doi:10.1007/s12282-022-01355-z.
   PubMed Web of Science ®Google Scholar
• Tarasiuk A, Mosińska P, Fichna J. The mechanisms linking obesity to colon cancer: An overview. Obes Res Clin Pract. 2018; 12(3):251–9. doi:10.1016/j.orcp.2018.01.005.
   PubMed Web of Science ®Google Scholar
• Uyar GO, Sanlier N. Association of Adipokines and Insulin, Which Have a Role in Obesity, with Colorectal Cancer. Eurasian J Med. 2019; 51(2):191–5. doi:10.5152/eurasianjmed.2018.18089.
   PubMed Web of Science ®Google Scholar
• Mihajlović M, Ninić A, Ostojić M, Sopić M, Stefanović A, Vekić J, Antonić T, Zeljković D, Trifunović B, Spasojević-Kalimanovska V, et al. Association of Adiponectin Receptors with Metabolic and Immune Homeostasis Parameters in Colorectal Cancer: in Silico Analysis and Observational Findings. Int J Environ Res Public Health. 2022;19(22):14995. doi:10.3390/ijerph192214995.
   PubMed Web of Science ®Google Scholar
• Deng L, Zhao X, Chen M, Ji H, Zhang Q, Chen R, Wang Y. Plasma adiponectin, visfatin, leptin, and resistin levels and the onset of colonic polyps in patients with prediabetes. BMC Endocr Disord. 2020; 20(1):63. doi:10.1186/s12902-020-0540-7.
   PubMed Web of Science ®Google Scholar
• Choe EK, Yi JW, Chai YJ, Park KJ. Upregulation of the adipokine genes ADIPOR1 and SPP1 is related to poor survival outcomes in colorectal cancer. J Surg Oncol. 2018; Jun117(8):1833–40. doi:10.1002/jso.25078.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wen K, Han X, Liu R, Qu Q. Adiponectin mediates antiproliferative and apoptotic responses in endometrial carcinoma by the AdipoRs/AMPK pathway. GynecolOncol. 2015; y137(2):311–20. doi:10.1016/j.ygyno.2015.02.012.
   PubMed Web of Science ®Google Scholar
• Sugiyama M, Takahashi H, Hosono K, Endo H, Kato S, Yoneda K, Nozaki Y, Fujita K, Yoneda M, Wada K, et al. Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int J Oncol. 2009;34(2):339–44. Feb
   PubMed Web of Science ®Google Scholar
• Moon HS, Liu X, Nagel JM, Chamberland JP, Diakopoulos KN, Brinkoetter MT, Hatziapostolou M, Wu Y, Robson SC, Iliopoulos D, et al. Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice. Gut. 2013;62(4):561–70. doi:10.1136/gutjnl-2012-302092.
   PubMed Web of Science ®Google Scholar
• Saxena A, Chumanevich A, Fletcher E, Larsen B, Lattwein K, Kaur K, Fayad R. Adiponectin deficiency: role in chronic inflammation induced colon cancer. Biochim Biophys Acta. 2012; 1822(4):527–36. doi:10.1016/j.bbadis.2011.12.006.
   PubMed Web of Science ®Google Scholar
• Ogunwobi OO, Beales IL. Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells. Regul Pept. 2006; 134(2-3):105–13. doi:10.1016/j.regpep.2006.02.001.
   PubMedGoogle Scholar
• Chakraborty D, Jin W, Wang J. The bifurcated role of adiponectin in colorectal cancer. Life Sci. 2021; Aug 1278:119524. doi:10.1016/j.lfs.2021.119524.
   PubMed Web of Science ®Google Scholar
• Sinicrope FA, Shi Q, Smyrk TC, Goldberg RM, Cohen SJ, Gill S, Kahlenberg MS, Nair S, Shield AF, Jahagirdar BN, et al. Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon Cancer. JNCI Cancer Spectr. 2021; 5(5):pkab070. doi:10.1093/jncics/pkab070.
   PubMed Web of Science ®Google Scholar
• Boccellino M, Ambrosio P, Ballini A, De Vito D, Scacco S, Cantore S, Feola A, Di Donato M, Quagliuolo L, Sciarra A, et al. The Role of Curcumin in Prostate CancerCells and DerivedSpheroids. Cancers (Basel). 2022;14(14):3348. doi:10.3390/cancers14143348.
   PubMed Web of Science ®Google Scholar
• Burton AJ, Gilbert R, Tilling K, Langdon R, Donovan JL, Holly JMP, Martin RM. Circulating adiponectin and leptin and risk of overall and aggressive prostate cancer: a systematic review and meta-analysis. Sci Rep. 2021; 11(1):320. doi:10.1038/s41598-020-79345-4.
   PubMed Web of Science ®Google Scholar
• Cancel M, Pouillot W, Mahéo K, Fontaine A, Crottès D, Fromont G. Interplay between Prostate Cancer and Adipose Microenvironment: A Complex and Flexible Scenario. Int J Mol Sci. 2022; 23(18):10762. doi:10.3390/ijms231810762.
   PubMed Web of Science ®Google Scholar
• Kaklamani V, Yi N, Zhang K, Sadim M, Offit K, Oddoux C, Ostrer H, Mantzoros C, Pasche B. Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. Metabolism. 2011; 60(9):1234–43. doi:10.1016/j.metabol.2011.01.005.
   PubMed Web of Science ®Google Scholar
• Méndez-Hernández A, Gallegos-Arreola MP, Moreno-Macías H, Espinosa Fematt J, Pérez-Morales R. LEP rs7799039, LEPR rs1137101, and ADIPOQ rs2241766 and 1501299 Polymorphisms Are Associated With Obesity and Chemotherapy Response in Mexican Women With Breast Cancer. Clin Breast Cancer. 2017; 17(6):453–62. doi:10.1016/j.clbc.2017.03.010.
   PubMed Web of Science ®Google Scholar
• Mistry T, Digby JE, Chen J, Desai KM, Randeva HS. The regulation of adiponectin receptors in human prostate cancer cell lines. Biochem Biophys Res Commun. 2006; 348(3):832–8. doi:10.1016/j.bbrc.2006.07.139.
   PubMed Web of Science ®Google Scholar
• Gao Q, Zheng J. Adiponectin-induced antitumor activity on prostatic cancers through inhibiting proliferation. Cell Biochem Biophys. 2014; 70(1):461–5. doi:10.1007/s12013-014-9941-4.
   PubMed Web of Science ®Google Scholar
• Gao Q, Zheng J, Yao X, Peng B. Adiponectin inhibits VEGF-A in prostate cancer cells. Tumour Biol. 2015; 36(6):4287–92. doi:10.1007/s13277-015-3067-1.
   PubMedGoogle Scholar
• Lu JP, Hou ZF, Duivenvoorden WC, Whelan K, Honig A, Pinthus JH. Adiponectin inhibits oxidative stress in human prostate carcinoma cells. Prostate Cancer Prostatic Dis. 2012; 15(1):28–35. doi:10.1038/pcan.2011.53.
   PubMed Web of Science ®Google Scholar
• Hu MB, Xu H, Hu JM, Zhu WH, Yang T, Jiang HW, Ding Q. Genetic polymorphisms in leptin, adiponectin and their receptors affect risk and aggressiveness of prostate cancer: evidence from a meta-analysis and pooled-review. Oncotarget. 2016; 7(49):81049–61. doi:10.18632/oncotarget.12747.
   PubMedGoogle Scholar
• Gu C, Qu Y, Zhang G, Sun L, Zhu Y, Ye D. A single nucleotide polymorphism in ADIPOQ predicts biochemical recurrence after radical prostatectomy in localized prostate cancer. Oncotarget. 2015; 6(31):32205–11. doi:10.18632/oncotarget.4980.
   PubMedGoogle Scholar
• Jiang H, Hu D, Wang J, Zhang B, He C, Ning J. Adiponectin and the risk of gastrointestinal cancers in East Asians: mendelian randomization analysis. Cancer Med. 2022; 11(12):2397–404. doi:10.1002/cam4.4735.
   PubMed Web of Science ®Google Scholar
• Shikawa M, Kitayama J, Yamauchi T, Kadowaki T, Maki T, Miyato H, Yamashita H, Nagawa H. Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2. Cancer Sci. 2007; 98(7):1120–7. doi:10.1111/j.1349-7006.2007.00486.x.
   PubMed Web of Science ®Google Scholar
• Hamabe-Horiike T, Harada SI, Yoshida K, Kinoshita J, Yamaguchi T, Fushida S. Adipocytes contribute to tumor progression and invasion of peritoneal metastasis by interacting with gastric cancer cells as cancer associated fibroblasts. Cancer Rep (Hoboken). 2023; 6(1):e1647. doi:10.1002/cnr2.1647.
   PubMedGoogle Scholar
• Lin YC, Lin G, Yeh TS. Visceral-to-subcutaneous fat ratio independently predicts the prognosis of locally advanced gastric cancer—- highlighting the role of adiponectin receptors. Eur J Surg Oncol. 2021; 47(12):3064–73. doi:10.1016/j.ejso.2021.04.028.
   PubMed Web of Science ®Google Scholar
• Kordafshari M, Nourian M, Mehrvar N, Jalaeikhoo H, Etemadi A, Khoshdel AR, Idris MG, Iravani S, Mehrvar A. Expression of AdipoR1 and AdipoR2 and Serum Level of Adiponectin in Gastric Cancer. Gastrointest Tumors. 2020; 7(4):103–9. doi:10.1159/000510342.
   PubMed Web of Science ®Google Scholar
• Otani K, Kitayama J, Kamei T, Soma D, Miyato H, Yamauchi T, Kadowaki T, Nagawa H. Adiponectin receptors are downregulated in human gastric cancer. J Gastroenterol. 2010; 45(9):918–27. doi:10.1007/s00535-010-0228-2.
   PubMed Web of Science ®Google Scholar
• Wu X, Chen P, Ou Y, Liu J, Li C, Wang H, Qiang F. Association of variants on ADIPOQ and AdipoR1 and the prognosis of gastric cancer patients after gastrectomy treatment. Mol Biol Rep. 2015; 42(2):355–61. doi:10.1007/s11033-014-3775-4.
   PubMed Web of Science ®Google Scholar
• Ye L, Zhang ZY, Du WD, Schneider ME, Qiu Y, Zhou Y, Zhou FS, Zuo XB, Chen G, Ma XL, et al. Genetic analysis of ADIPOQ variants and gastric cancer risk: a hospital-based case-control study in China. Med Oncol. 2013;30(3):658. doi:10.1007/s12032-013-0658-9.
   PubMed Web of Science ®Google Scholar
• Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial cancer. Lancet. 2022; 399(10333):1412–28. doi:10.1016/S0140-6736(22)00323-3.
   PubMed Web of Science ®Google Scholar
• Cust AE, Kaaks R, Friedenreich C, Bonnet F, Laville M, Lukanova A, Rinaldi S, Dossus L, Slimani N, Lundin E, et al. Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab. 2007;92(1):255–63. doi:10.1210/jc.2006-1371.
   PubMed Web of Science ®Google Scholar
• Ashizawa N, Yahata T, Quan J, Adachi S, Yoshihara K, Tanaka K. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects. Gynecol Oncol. 2010; 119(1):65–9. doi:10.1016/j.ygyno.2010.07.007.
   PubMed Web of Science ®Google Scholar
• Li R, Dong F, Zhang L, Ni X, Lin G. Role of adipocytokines in endometrial cancer progression. Front Pharmacol. 2022; 13:1090227. doi:10.3389/fphar.2022.1090227.
   PubMed Web of Science ®Google Scholar
• Słabuszewska-Jóźwiak A, Lukaszuk A, Janicka-Kośnik M, Wdowiak A, Jakiel G. Role of Leptin and Adiponectin in Endometrial Cancer. Int J Mol Sci. 2022; 23(10):5307. doi:10.3390/ijms23105307.
   PubMed Web of Science ®Google Scholar
• Moon HS, Chamberland JP, Aronis K, Tseleni-Balafouta S, Mantzoros CS. Direct role of adiponectin and adiponectin receptors in endometrial cancer: in vitro and ex vivo studies in humans. Mol Cancer Ther. 2011; 10(12):2234–43. doi:10.1158/1535-7163.MCT-11-0545.
   PubMed Web of Science ®Google Scholar
• Coll-de la Rubia E, Martinez-Garcia E, Dittmar G, Gil-Moreno A, Cabrera S, Colas E. Prognostic Biomarkers in Endometrial Cancer: A Systematic Review and Meta-Analysis. J Clin Med. 2020; 9(6):1900. doi:10.3390/jcm9061900.
   PubMed Web of Science ®Google Scholar
• Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE, Parsons R. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A. 1999; 696(4):1563–8. doi:10.1073/pnas.96.4.1563.
   PubMed Web of Science ®Google Scholar
• Morielli AR, Kokts-Porietis RL, Benham JL, McNeil J, Cook LS, Courneya KS, Friedenreich CM. Associations of insulin resistance and inflammatory biomarkers with endometrial cancer survival: the Alberta endometrial cancer cohort study. Cancer Med. 2022; 11(7):1701–11. doi:10.1002/cam4.4584.
   PubMed Web of Science ®Google Scholar
• Yan Y, Shi H, Zhao Z, Wang S, Zhou S, Mu Y, Ding N, Lai Y, Zhao AZ, Cheng L, et al. Adiponectin deficiency promotes endometrial carcinoma pathogenesis and development via activation of mitogen-activated protein kinase. J Pathol. 2022;257(2):146–57. doi:10.1002/path.5874.
   PubMed Web of Science ®Google Scholar
• Naaman SC, Shen S, Zeytinoglu M, Iyengar NM. Obesity and Breast Cancer Risk: the Oncogenic Implications of Metabolic Dysregulation. J Clin Endocrinol Metab. 2022; 107(8):2154–66. doi:10.1210/clinem/dgac241.
   PubMed Web of Science ®Google Scholar
• Cong L, Gasser J, Zhao J, Yang B, Li F, Zhao AZ. Human adiponectin inhibits cell growth and induces apoptosis in human endometrial carcinoma cells, HEC-1-A and RL95 2. Endocr Relat Cancer 2007 Sep;14(3):713–20. doi:10.1677/ERC-07-0065. Erratum in: endocrRelat Cancer. 2007 Dec;14(4):1127.
   PubMed Web of Science ®Google Scholar